A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/1999
10/13/1999	CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999	CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/12/1999	US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis
10/12/1999	US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999	US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999	US5965549 Ciprofloxacin-hydrocortisone suspension
10/12/1999	US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999	US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999	US5965152 Controlled release of miotic and mydriatic drugs in the anterior chamber
10/07/1999	WO1999050268A2 Substituted indolealkanoic acids
10/07/1999	WO1999050249A2 Pyrimidines and triazines as integrin antagonists
10/07/1999	WO1999050247A1 Compounds with activity on muscarinic receptors
10/07/1999	WO1999050241A1 C11 oxymyl and hydroxylamino prostaglandins useful as medicaments
10/07/1999	WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999	WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999	WO1999037292A3 Carbonic anhydrase inhibitor for increasing oxygen tension in the optic nerve and retina
10/07/1999	WO1999021996A9 Methods and compositions for the diagnosis and treatment of cataracts
10/07/1999	CA2543133A1 Compounds with activity on muscarinic receptors
10/07/1999	CA2333927A1 Pyrimidines and triazines as integrin antagonists
10/06/1999	EP0947506A1 2-Aza-bicyclo[2.2.1]heptane derivatives and their use as rotamase inhibitors
10/06/1999	EP0947496A1 Bicyclic aromatic compounds and their use in human and veterinary medicine as well as in cosmetology
10/06/1999	EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999	EP0946587A2 New amide compounds
10/06/1999	EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999	EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999	EP0946541A1 Quinolines and their therapeutic use
10/06/1999	EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999	EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
10/06/1999	EP0946196A1 Method for treating symptoms of diabetes
10/06/1999	EP0946181A1 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
10/06/1999	EP0946175A1 USE OF AN H+, K+ -ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS
10/06/1999	EP0946171A1 Ophtalmic viscoelastic compositions
10/06/1999	EP0946164A1 Integrin antagonists
10/06/1999	EP0946157A2 The topical use of kappa opioid agonists to treat ocular pain
10/06/1999	EP0722326A4 Highly sulfated maltooligosaccharides with heparin-like properties
10/06/1999	CN1230882A Method and composition for rewetting contact lenses and relieving eye dryness
10/06/1999	CN1045443C Novel purine derivatives and pharmaceutically acceptable salts thereof
10/05/1999	US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999	US5962529 Metalloproteinase inhibitors
10/05/1999	US5962502 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
10/05/1999	US5962490 Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
10/05/1999	US5962473 Methods of treating or ameliorating the symptoms of common cold or allergic rhinitis with serotonin 5-HT1F
10/05/1999	US5962457 2,3 Disubstituted- (5,6)-heteroarylfused-pyrimidine-4-ones
10/05/1999	US5962230 Diagnosis and treatment of glaucoma
10/05/1999	US5961977 Orally administering an autoantigen
09/1999
09/30/1999	WO1999049039A2 GFRα3 AND ITS USES
09/30/1999	WO1999048881A1 Metalloproteinase inhibitors
09/30/1999	WO1999048868A2 Heterocyclic classes of compounds for the modulating tyrosine protein kinase
09/30/1999	WO1999048858A2 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999	WO1999048495A1 Benzoates derivatives for inhibiting angiogenesis
09/30/1999	WO1999048361A1 Xylitol compositions for treating upper respiratory conditions
09/30/1999	WO1999006340A3 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
09/30/1999	CA2325943A1 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
09/30/1999	CA2325935A1 Heterocyclic families of compounds for the modulation of tyrosine protein kinase
09/30/1999	CA2324347A1 Benzoates derivatives for inhibiting angiogenesis
09/29/1999	EP0945464A1 Specific binding members for human transforming growth factor beta; materials and methods
09/29/1999	EP0944630A1 Xanthines and their therapeutic use
09/29/1999	EP0944622A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
09/29/1999	EP0944621A1 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
09/29/1999	EP0944620A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
09/29/1999	EP0944619A1 Novel integrin receptor antagonists
09/29/1999	EP0944618A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use
09/29/1999	EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use
09/29/1999	EP0944604A1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
09/29/1999	EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
09/29/1999	EP0944593A2 $i(CIS)-$g(D)?4 ANALOGS OF PROSTAGLANDINS AS OCULAR HYPOTENSIVES
09/29/1999	EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors
09/29/1999	EP0944395A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye
09/29/1999	EP0944388A2 Inhibitors of farnesyl-protein transferase
09/29/1999	EP0642789B1 Remedy for glaucoma
09/29/1999	EP0593520B1 Ocular compositions containing steroids and their use in treating glaucoma
09/29/1999	CN1230222A PTX-sensitive G proteins, prodn. and use thereof
09/28/1999	US5959123 Reacating substituted amino acid with 3-amino-4-substituted-azetidine-2-one compound to form 3, 4-disubstituted-azetidine-2-one compound; useful for treating muscular dystrophy, arthritis, viral and parasitic infections
09/28/1999	US5958931 Phenyl-substituted 5H-thiazolo 3,2-A!pyrimidine derivative glutamate receptor antagonists
09/28/1999	US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
09/28/1999	US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
09/28/1999	US5958891 Administering vector comprising gene encoding dust mite allergen by intramuscular injection to prevent airway hyperreactivity or airway inflammation
09/28/1999	US5958731 Cell junction PDZ protein
09/28/1999	US5958401 Method of using IL-11 for treating psoriasis
09/23/1999	WO1999047490A1 Bicyclo[2.2.1]heptanes and related compounds
09/23/1999	WO1999047120A1 Ophthalmic solution comprising glycogen
09/23/1999	DE19811683A1 Ophthalmological use of fluorocarbon with low dissolved oxygen content, e.g. for treating ischemic retinal disease
09/23/1999	CA2322742A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
09/22/1999	EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses
09/22/1999	EP0655063B1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension
09/22/1999	CN1229407A Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same
09/22/1999	CN1229357A Method of inhibiting fibrosis with growth inhibition excitant
09/21/1999	US5955487 Treating high blood pressure, cardiac insufficiency, glaucoma
09/21/1999	US5955089 Streptococcus for vaccines
09/21/1999	CA2135751C 4-mercaptoacetylamino-¬2\| benzazepinone(3) derivatives, and use as enkephalinase inhibitors
09/16/1999	WO1999046367A2 Methods of diagnosis and triage using cell activation measures
09/16/1999	WO1999045952A2 Method of preventing the death of retinal neurons and treating ocular diseases
09/16/1999	WO1999045920A2 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
09/16/1999	WO1999045919A1 Phenanthrofuran derivatives
09/16/1999	WO1999045869A1 Use of corneal hardening agents in enzyme orthokeratology
09/16/1999	WO1999045776A1 Treatment of respiratory disease and otitis media
09/16/1999	WO1999029878A3 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
09/16/1999	CA2575850A1 The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation
09/16/1999	CA2323199A1 Use of corneal hardening agents in enzyme orthokeratology
09/16/1999	CA2322962A1 Phenanthrofuran derivatives

1 ... 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 ... 531